SCHEMBL25857137

SCHEMBL25857137

CC(C)(C)OC(=O)/N=C(\NCCN1C(=O)C2C3C=CC(O3)C2C1=O)NC(=O)OC(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.41
OPRD1 P41143 1/20 0.41
OPRK1 P41145 1/20 0.41
ALDH1A1 P00352 10/20 0.36
AKT1 P31749 1/20 0.34
NPC1 O15118 3/20 0.33
RAB9A P51151 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
TP53 P04637 1/20 0.33
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
HPGD P15428 2/20 0.32
HSD17B10 Q99714 2/20 0.32
MAPT P10636 1/20 0.32
HTT P42858 1/20 0.32
CACNA1B Q00975 1/20 0.32
APBA1 Q02410 1/20 0.32
ATM Q13315 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19388140 1.00 OPRM1 (0.41) OPRM1OPRD1OPRK1ALDH1A1AKT1
SCHEMBL22863834 0.86 OPRM1 (0.47) OPRM1OPRD1OPRK1ALDH1A1AKT1
SCHEMBL18666981 0.86 OPRM1 (0.47) OPRM1OPRD1OPRK1ALDH1A1AKT1
SCHEMBL22100058 0.86 OPRM1 (0.43) OPRM1OPRD1OPRK1ALDH1A1NPC1
SCHEMBL22100089 0.85 OPRM1 (0.43) OPRM1OPRD1OPRK1ALDH1A1NPC1
SCHEMBL25857161 0.85 KDM4E (0.32) ALDH1A1AKT1
SCHEMBL24746668 0.85 ALDH1A1 (0.44) OPRM1OPRD1OPRK1ALDH1A1AKT1
SCHEMBL24746667 0.84 ALDH1A1 (0.43) OPRM1OPRD1OPRK1ALDH1A1AKT1
SCHEMBL24747003 0.82 ALDH1A1 (0.43) OPRM1OPRD1OPRK1ALDH1A1AKT1
SCHEMBL24746656 0.82 ALDH1A1 (0.45) OPRM1OPRD1OPRK1ALDH1A1AKT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11801228-B2 Modified guanidine-containing polymers for biologic delivery THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) 2023-10-31 US disclosed
US-20230225982-A1 MODIFIED GUANIDINE-CONTAINING POLYMERS FOR BIOLOGIC DELIVERY THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) 2023-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230225982-A1 MODIFIED GUANIDINE-CONTAINING POLYMERS FOR BIOLOGIC DELIVERY GMPS, RNMT, GUCY1A1 OPRM1 2522/4885OPRD1 3897/4885OPRK1 3789/4885
US-11801228-B2 Modified guanidine-containing polymers for biologic delivery GMPS, RNMT, GUCY1A1 OPRM1 2522/4885OPRD1 3897/4885OPRK1 3789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.